DIG:ARCA-ProShares Ultra Oil & Gas (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 35.19

Change

0.00 (0.00)%

Market Cap

USD 0.17B

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Dow Jones U.S. Oil & GasSM Index. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index measures the performance of the oil and gas sector of the U.S. equity market. Component companies include, among others, exploration and production, integrated oil and gas, oil equipment and services, pipelines, renewable energy equipment companies and alternative fuel producers. The fund is non-diversified.

Inception Date: 30/01/2007

Primary Benchmark: DJ US Oil&Gas TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.08%

Management Expense Ratio: 0.95 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
SCPS Scopus Biopharma Inc 6.00 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-25 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

+0.09 (+0.30%)

USD 9.92B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

-5.58 (-0.84%)

USD 7.96B
QLD ProShares Ultra QQQ 0.95 %

-0.21 (-0.18%)

USD 7.84B
SSO ProShares Ultra S&P500 0.90 %

+0.02 (+0.02%)

USD 5.60B
UPRO ProShares UltraPro S&P500 0.92 %

-0.01 (-0.01%)

USD 4.27B
TECL Direxion Daily Technology Bull.. 1.17 %

+0.25 (+0.25%)

USD 3.43B
YINN Direxion Daily FTSE China Bull.. 1.02 %

+0.30 (+1.01%)

USD 1.61B
USD ProShares Ultra Semiconductors 0.95 %

+0.31 (+0.44%)

USD 1.16B
UDOW ProShares UltraPro Dow30 0.95 %

+0.47 (+0.47%)

USD 0.91B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

+2.05 (+2.13%)

USD 0.82B

ETFs Containing DIG

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.22% 24% F 25% F
Dividend Return 3.07% 89% A- 46% F
Total Return -1.15% 29% F 24% F
Trailing 12 Months  
Capital Gain -7.69% 16% F 21% F
Dividend Return 2.96% 89% A- 45% F
Total Return -4.72% 24% F 20% F
Trailing 5 Years  
Capital Gain 10.53% 55% F 56% F
Dividend Return 8.29% 92% A 24% F
Total Return 18.82% 59% D- 47% F
Average Annual (5 Year Horizon)  
Capital Gain 111.10% 88% B+ 97% N/A
Dividend Return 114.69% 88% B+ 97% N/A
Total Return 3.60% 95% A 71% C-
Risk Return Profile  
Volatility (Standard Deviation) 405.63% 13% F 3% F
Risk Adjusted Return 28.28% 52% F 42% F
Market Capitalization 0.17B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.